avastin
Roche’s Avastin set for new ovarian cancer indication in Europe
September 26, 2011Sales and Marketing avastin, ovarian cancer
Roche’s Avastin has gained the backing of European regulatory advisors for a new indication in ovarian cancer. The European Medicines …
Avastin faces greater scrutiny over eye disease use
September 23, 2011Sales and Marketing avastin, macular oedema
The use of Roche’s Avastin to treat eye disease has come under greater scrutiny after a series of infections in …
Roche to show new cancer data at European congress
September 20, 2011Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin
Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …
NICE rejects three bowel cancer drugs
September 5, 2011Sales and Marketing Erbitux, NICE, Vectibix, avastin, colorectal cancer
NICE says three treatments – Roche’s Avastin, Merck KgAa’s Erbitux and Amgen’s Vectibix – are all not cost effective in …
EMA extends Avastin breast cancer licence
July 1, 2011Sales and Marketing avastin, breast cancer, metastatic breast cancer
The EMA has extended the breast cancer licence for Roche’s Avastin after initially restricting the drug’s use. The decision comes …
FDA advisers reject Avastin appeal
June 30, 2011Sales and Marketing FDA, avastin
An FDA advisory panel has refused to back Roche’s Avastin in advanced breast cancer after ruling it neither safe nor …
NHS failed to use extra cancer drug funds
June 17, 2011Sales and Marketing Cancer, Cancer Drugs Fund, Erbitux, avastin
The million pound fund set up to increase NHS uptake of new cancer drugs was widely underused, with just over …
Government wrong to push for Avastin in eye disease, says charity
May 12, 2011Research and Development, Sales and Marketing Lucentis, RNIB, avastin, wet AMD
The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …
Avastin as effective as Lucentis in eye disease
May 4, 2011Research and Development Lucentis, avastin, off label, wet AMD
Roche’s cancer drug Avastin is as effective at treating wet AMD as Novartis’ Lucentis, which is licensed for the eye …
Avastin’s breast cancer use to continue in Europe
March 2, 2011Sales and Marketing CHMP, Cancer, European Commission, Roche, avastin, bevacizumab, breast cancer, docetaxel, paclitaxel
Roche’s Avastin will remain on the market as a treatment for breast cancer, but only in combination with paclitaxel, the …
NICE yes for Votrient, no to Avastin
February 23, 2011Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer
NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …
Roche eyes ovarian cancer expansion for Avastin
February 8, 2011Sales and Marketing Cancer, Roche, avastin, bevacizumab, ovarian cancer
Roche has submitted an EU marketing authorisation for Avastin for the treatment of ovarian cancer and plans to file the …
Survey shows doctors support FDA Avastin decision
February 7, 2011Sales and Marketing FDA, Roche, Sermo, avastin, bevacizumab
A survey of US doctors suggests that a majority support the FDA’s decision to take away Avastin’s licence for use …
Roche weathers tough year and looks to pipeline for 2011
February 3, 2011Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab
Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …
Study highlights Avastin heart failure risk
January 6, 2011Research and Development, Sales and Marketing Roche, avastin, bevacizumab, breast cancer
A new study confirms that Roche’s Avastin is linked to a small but significant increased risk of heart failure in …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
